| Date Filed | Type | Description |
| 01/04/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/12/2022 |
SC 13G/A
| Meditor Group Ltd reports a 7.1% stake in Esperion Therapeutics, Inc. |
| 01/06/2021 |
SC 13G/A
| Meditor Group Ltd reports a 9.6% stake in Esperion Therapeutics, Inc. |
| 01/06/2020 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 04/09/2019 |
SC 13G/A
| Meditor Group Ltd reports a 5% stake in Exelixis, Inc. |
| 01/03/2019 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 01/02/2019 |
SC 13G/A
| Meditor Group Ltd reports a 5.3% stake in Exelixis, Inc. |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/21/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2013 |
SC 13G/A
| Meditor Group Ltd reports a 6.5% stake in Exelixis, Inc. |
| 08/20/2012 |
SC 13G
| Meditor Group Ltd reports a 5.3% stake in Exelixis, Inc. |
| 08/17/2012 |
SC 13G/A
| Meditor Group Ltd reports a 5.1% stake in Vivus, Inc. |
| 07/26/2012 |
SC 13G/A
| Meditor Group Ltd reports a 4.6% stake in Vivus, Inc. |
| 07/26/2012 |
SC 13G/A
| Meditor Group Ltd reports a 5.8% stake in Vivus, Inc. |
| 05/03/2012 |
SC 13G/A
| Meditor Group Ltd reports a 4.7% stake in Vivus, Inc. |
| 03/21/2012 |
SC 13G/A
| Meditor Group Ltd reports a 6.3% stake in Vivus, Inc. |
| 03/28/2008 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/18/2008 |
SC 13G
| Meditor Group Ltd reports a 5.2% stake in Vion Pharmaceuticals, Inc. |
| 02/15/2008 |
SC 13G
| Meditor Group Ltd reports a 7.6% stake in Vion Pharmaceuticals, Inc. |
| 02/05/2008 |
SC 13G
| Meditor Group Ltd reports a 7.8% stake in Vion Pharmaceuticals, Inc. |
| 01/18/2008 |
SC 13G
| Meditor Group Ltd reports a 7.8% stake in Vion Pharmaceuticals, Inc. |
| 09/26/2007 |
SC 13G
| Meditor Group Ltd reports a 5% stake in Cypress Bioscience, Inc. |
| 09/12/2007 |
SC 13G
| Meditor Group Ltd reports a 5.1% stake in Cypress Bioscience, Inc. |
| 09/12/2007 |
SC 13G
| Meditor Group Ltd reports a 4.8% stake in Onyx Pharmaceuticals, Inc. |
| 09/07/2007 |
SC 13G
| Meditor Group Ltd reports a 5.8% stake in Onyx Pharmaceuticals, Inc. |
| 08/16/2007 |
SC 13G
| Meditor Group Ltd reports a 6.9% stake in Onyx Pharmaceuticals, Inc. |
| 07/27/2007 |
SC 13G
| Meditor Group Ltd reports a 7.8% stake in Onyx Pharmaceuticals, Inc. |
| 07/26/2007 |
SC 13G
| Meditor Group Ltd reports a 4% stake in Acusphere, Inc. |
| 07/13/2007 |
SC 13G
| Meditor Group Ltd reports a 5.7% stake in Acusphere, Inc. |
| 07/03/2007 |
SC 13G
| Meditor Group Ltd reports a 8.7% stake in Onyx Pharmaceuticals, Inc. |
| 07/03/2007 |
SC 13G
| Meditor Group Ltd reports a 6.1% stake in Acusphere, Inc. |
| 06/25/2007 |
SC 13G
| Meditor Group Ltd reports a 8.7% stake in Onyx Pharmaceuticals, Inc. |
|